| Literature DB >> 29890037 |
Coen C W G Bongers1, Mohammad Alsady2, Tom Nijenhuis3, Anouk D M Tulp1, Thijs M H Eijsvogels1,4, Peter M T Deen2, Maria T E Hopman1.
Abstract
Exercise and dehydration may be associated with a compromised kidney function and potential signs of kidney injury. However, the kidney responses to exercise of different durations and hypohydration levels are not yet known. Therefore, we aimed to compare the effects of acute versus prolonged exercise and dehydration on estimated glomerular filtration rate (eGFR) and kidney injury biomarkers in healthy male adults. A total of 35 subjects (23 ± 3 years) were included and invited for two study visits. Visit 1 consisted of a maximal cycling test. On Visit 2, subjects performed a submaximal exercise test at 80% of maximal heart rate until 3% hypohydration. Blood and urine samples were taken at baseline, after 30 min of exercise (acute effects; low level of hypohydration) and after 150 min of exercise or when 3% hypohydration was achieved (prolonged effects, high level of hypohydration). Urinary outcome parameters were corrected for urinary cystatin C, creatinine, and osmolality. Subjects dehydrated on average 0.6 ± 0.3% and 2.9 ± 0.7% after acute and prolonged exercise, respectively (P < 0.001). The eGFRcystatin C did not differ between baseline and acute exercise (118 ± 11 vs. 116 ± 12 mL/min/1.73 m2 , P = 0.12), whereas eGFRcystatin C was significantly lower after prolonged exercise (103 ± 16 mL/min/1.73 m2 , P < 0.001). We found no difference in osmolality corrected uKIM1 concentrations after acute and prolonged exercise (P > 0.05), and elevated osmolality corrected uNGAL concentrations after acute and prolonged exercise (all P-values < 0.05). In conclusion, acute exercise did barely impact on eGFRcystatin C and kidney injury biomarkers, whereas prolonged exercise is associated with a decline in eGFRcystatin C and increased biomarkers for kidney injury.Entities:
Keywords: Kidney function; kidney injury molecule-1; neutrophil gelatinase-associated lipocalin; renal damage; renal function
Mesh:
Substances:
Year: 2018 PMID: 29890037 PMCID: PMC5995308 DOI: 10.14814/phy2.13734
Source DB: PubMed Journal: Physiol Rep ISSN: 2051-817X
Subject characteristics and results of maximal exercise test (n = 34)
| Parameter | Total group ( |
|---|---|
| Subject characteristics | |
| Age (years) | 22.8 ± 2.9 |
| Length (m) | 1.83 ± 0.06 |
| Body mass (kg) | 74.6 ± 10.5 |
| BMI (kg/m2) | 22.5 ± 3.6 |
| Systolic blood pressure (mmHg) | 128 ± 10 |
| Diastolic blood pressure (mmHg) | 69 ± 9 |
| Resting heart rate (bpm) | 66 ± 14 |
| Serum Creatinine (μmol/L) | 84.3 ± 8.9 |
| eGFRcreatinine (mL/min/1.73 m2) | 110.8 ± 11.0 |
| Activity score (au) | 8579 ± 4127 |
| Maximal exercise test | |
| VO2 max (mL/min/kg) | 56.6 ± 10.6 |
| HR max (bpm) | 194 ± 9 |
| Maximal workload (W) | 338 ± 55 |
| Blood lactate level (mmol/L) | 12.9 ± 1.8 |
| RER (ratio: VCO2/VO2) | 1.18 ± 0.07 |
| Rate of perceived exertion (au) | 8.2 ± 1.2 |
Subject characteristics for the total group. Data were presented as mean ± SD. MET, Metabolic equivalent of task, eGFR, estimated glomerular filtration ratio, bpm, beats per minute, au, arbitrary unit.
Fluid balance responses
| Parameter | Baseline | Acute exercise | Prolonged exercise |
|
|---|---|---|---|---|
| Relative body mass loss (%) | – | 0.6 ± 0.3 | 2.9 ± 0.7 |
|
| Plasma hemoglobin (mmol/L) | 9.2 ± 0.7 | 9.6 ± 0.6 | 9.7 ± 0.6 |
|
| Plasma hematocrit (L/L) | 0.47 ± 0.03 | 0.48 ± 0.03 | 0.49 ± 0.03 |
|
| Plasma volume loss (%) | – | 3.5 ± 2.1 | 4.8 ± 2.2 |
|
| Urine Osmolality (mOsm/kg) | 364 (201–624) | 585 (360–735) | 837 (728–961) |
|
| Serum Osmolality | 293 ± 7 | 294 ± 6 | 300 ± 6 |
|
| Serum Sodium | 142.2 ± 2.3 | 141.9 ± 2.7 | 144.0 ± 2.6 |
|
| Plasma copeptin (pmol/L) | 4.6 (3.3–7.4) | 6.6 (4.2–13.5) | 35.9 (25.7–47.6) |
|
| Plasma renin activity (pmol/L) | 1.6 (1.1–2.6) | 4.5 (3.2–5.7) | 13.4 (9.9–19.0) |
|
Bold indicates significant difference values.
Data were presented as mean ± SD or median (interquartile range).
Significantly different from baseline.
Different from acute exercise.
Figure 1The estimated glomerular filtration ratio calculated with the cystatin C formula at baseline and after acute and prolonged exercise. A Friedman test was used to examine differences over time, whereas a Wilcoxon signed‐rank test was used to assess differences acute and prolonged exercise. Data were presented as median with interquartile range. *Represents a difference between acute and prolonged exercise.
Urinary outcome parameters
| Parameter | Baseline | Acute exercise | Prolonged exercise |
|
|---|---|---|---|---|
| uCystatin C (mg/L) | 0.01 (0.01–0.04) | 0.03 (0.01–0.08) | 0.15 (0.09–0.26) |
|
| uCreatinine (mmol/L) | 5.0 (3.3–14.5) | 9.2 (5.5–19.1) | 26.3 (20.5–37.8) |
|
| uAlbumin (mg/mL) | 3.9 (2.1–7.1) | 10.0 (3.8–23.2) | 32.5 (16.4–50.1) |
|
| uAlbumin (mg/μg Cystatin C) | 308 (130–425) | 313 (150–821) | 161 (119–553) | 0.14 |
| uAlbumin (mg/mg Creatinine) | 6.0 (3.9–11.0) | 7.3 (5.3–14.4) | 7.9 (6.0–12.8) |
|
| uAlbumin (μg/mOsm) | 11.7 (7.6–21.0) | 17.5 (9.6–36.4) | 35.1 (20.9–63.4) |
|
| uGlucose (mmol/L) | 0.11 (0.10–0.28) | 0.17 (0.11–0.33) | 0.50 (0.33–0.79) |
|
| uGlucose (mmol/mg Cystatin C) | 5.7 (2.7–12.0) | 5.5 (3.5–17.0) | 3.1 (2.1–4.0) |
|
| uGlucose (mmol/g Creatinine) | 0.19 (0.15–0.24) | 0.18 (0.17–0.22) | 0.16 (0.13–0.18) |
|
| uGlucose (μmol/mOsm) | 3.4 (2.4–4.8) | 3.4 (2.7–5.1) | 5.4 (4.4–8.9) |
|
Bold indicates significant difference values.
Data were presented as mean ± SD or median (interquartile range).
Significantly different from baseline.
Different from acute exercise.
Figure 2Urinary NGAL concentration uncorrected (A), as well as after correction for cystatin C (B), creatinine (C), and osmolality (D), at baseline and after acute and prolonged exercise (n = 31). A Friedman test was used to examine differences in uNGAL over time, whereas a Wilcoxon signed‐rank test was used to assess differences acute and prolonged exercise. Data were presented as median (interquartile range) for uncorrected and creatinine and osmolality corrected. *Represents a significant difference from baseline, and ^ represents a difference from acute exercise.
Changes in uKIM1 and uNGAL compared to baseline
| Parameter | ∆ Acute exercise | ∆ Prolonged exercise |
|
|---|---|---|---|
| uKIM1 (ng/mL) | 0.7 (−0.2–2.1) | 3.0 (0.8–7.6) |
|
| uKIM1 (pg/ng Cystatin C) | 4.2 ± 72.0 | −20.1 ± 59.2 |
|
| uKIM1 (ng/mg Creatinine) | 0.1 (−0.9–1.0) | 0.1 (−0.9–1.5) | 0.69 |
| uKIM1 (pg/mOsm) | 0.8 (−1.1–2.4) | 2.7 (−0.1–8.2) |
|
| uNGAL (ng/mL) | 1.0 (0.0–8.0) | 11.1 (0.7–22.6) |
|
| uNGAL (pg/ng Cystatin C) | 30.1 (−49.5–84.3) | −15.1 (−86.5–55.8) |
|
| uNGAL (ng/mg Creatinine) | 1.8 ± 4.6 | 2.9 ± 8.8 | 0.58 |
| uNGAL (pg/mOsm) | 2.7 (−0.5–8.01) | 8.0 (0.2–28.6) |
|
Bold indicates significant difference values.
Data were presented as mean ± SD or median (interquartile range).
Figure 3Urinary KIM1 concentration uncorrected (A), as well as after correction for cystatin C (B), creatinine (C), and osmolality (D), at baseline and after acute and prolonged exercise (n = 22). A Friedman test was used to examine differences in uKIM1 over time, whereas a Wilcoxon signed‐rank test was used to assess differences acute and prolonged exercise. Data were presented as median (interquartile range). *Represents a significant difference from baseline, and ^represents a difference from acute exercise.